reglab/statecodes huggingface dataset:
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-7 - Exemption of Agents and Employees; Affiliated Practitioners

Current through July 13, 2024
(a) The requirement of registration is waived
				for any agent or employee of a person who is registered to engage in any group
				of independent activities, if such agent or employee is acting in the usual
				course of his business or employment.
(b) A practitioner (other than an intern,
				resident, or foreign physician) who is an agent or employee of another
				practitioner registered to dispense controlled substances may, when acting in
				the usual course of his employment, administer, and dispense (other than by
				issuance of prescription) controlled substances if and to the extent that such
				individual practitioner is authorized or permitted to do so by the jurisdiction
				in which he practices, under the registration of the employer or principal
				practitioner in lieu of being registered himself. (For example, a pharmacist
				employed by a pharmacy need not be registered individually to fill a
				prescription for controlled substances if a pharmacy is so
				registered.)
(c) A practitioner who
				is an intern, resident, or foreign physician may dispense and prescribe
				controlled substances under the registration of the hospital or other
				institution which is registered and by whom he is employed provided that:
(i) Such dispensing or prescribing is done in
				the usual course of his professional practice;
(ii) Such individual practitioner is
				authorized or permitted to do so by the laws of the State of Wyoming;
(iii) The hospital or other institutions by
				whom he is employed has determined that the practitioner is so permitted to
				dispense or prescribe drugs by the State of Wyoming;
(iv) Such practitioner is acting only within
				the scope of his employment in the hospital or institution;
(v) The hospital or other institution
				authorizes the intern, resident, or foreign physician to dispense or prescribe
				under the hospital registration and designates a specific internal code number
				for each intern, resident, or foreign physician so authorized. The code number
				shall consist of numbers, letters, or a combination thereof and shall be a
				suffix to the institution's DEA registration number, preceded by a hyphen
				(e.g., AP 0123456-10 or AP 0123456-A12;
(vi) A current list of internal codes and the
				corresponding practitioner is kept by the hospital or other institution and is
				made available to the public upon request for the purpose of verifying the
				authority of the prescribing practitioner.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-8 - Exemption of Certain Military and Other Personnel

Current through July 13, 2024
(a) The
				requirement of registration is waived for any official of the United States
				Army, Navy, Marine Corps, Air Force, Coast Guard, or Public Health Service who
				is authorized to prescribe, dispense, or administer, but not to procure or
				purchase, controlled substances in the course of his official duties. Such
				officials when issuing a prescription shall state the branch of service or
				agency (e.g., "U. S. Army" or "Public Health Service") and the service
				identification number of the issuing official in lieu of the registration
				number required on prescription forms. The service identification number for a
				Public Health Service employee is his Social Security identification
				number.
(b) If any official
				exempted by this section also engages as a private individual in any activity
				or group of activities for which registration is required, such official shall
				obtain a registration for such private activities.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-9 - Exemption of Law Enforcement Officials

Current through July 13, 2024
(a) The requirement
				of registration is waived for the following persons in the circumstances
				described in this section:
(i) Any officer or
				employee of the Drug Enforcement Administration, any officer of the United
				States Bureau of Customs, any officer or employee of the United States Food and
				Drug Administration, and any other Federal officer who is lawfully engaged in
				the enforcement of any Federal law relating to controlled substances, drugs or
				customs, and is duly authorized to possess controlled substances in the course
				of his official duties; and
(ii)
				Any officer or employee of any State, or any political subdivision or agency
				thereof, who is engaged in the enforcement of any State of local law relating
				to controlled substances and is duly authorized to possess controlled
				substances in the course of his official duties.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-10 - Exemption of Civil Defense Officials

Current through July 13, 2024
(a) The requirement
				of registration is waived for any official of a civil defense or disaster
				relief organization who, in the course of his official duties, is authorized
				to:
(i) Maintain, and distribute for such
				maintenance, controlled substances held for emergency use; or
(ii) Procure controlled substances for the
				purpose of maintaining supplies for emergency use, provided that all of such
				procurement is from the United States General Services Administration and in
				accordance with the rules of the United States office of Emergency
				Preparedness.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-11 - Time for Application for Registration; Expiration Date

Current through July 13, 2024
(a)
				Any person who is required to be registered and who is not so registered may
				apply for registration at any time. No person required to be registered shall
				engage in any activity for which registration is required until the application
				for registration is approved. The Board will issue a "Preliminary" approval so
				that the registrant may become registered with the Drug Enforcement
				Administration. After receiving the DEA number, the Board will register
				them.
(b) Any person who is
				registered may apply to be reregistered not less than thirty (30) days, nor
				more than sixty (60) days, before the expiration date of his
				registration.
(c) The expiration
				date of the registration of any person will be the last day of June of each
				year.
(d) Any registrant who fails
				to renew their registration by September 30th of each calendar year shall be
				penalized in the amount of $40.00. If failure to renew continues past December
				31st of the calendar year, the registration shall be cancelled and the Bureau
				notified for cancellation of the registrants' federal registration.
(e) Any registrant who wishes to reinstate
				their registration when said registration has lapsed only for failure to pay
				renewal fees, the registrant shall pay all back renewal fees, including annual
				fines, up to a maximum of five (5) years.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-12 - Application Forms; Contents; Signature

Current through July 13, 2024
(a) If any person
				is required to be registered, and is not so registered and is applying for
				registration, he should obtain the necessary forms from the officer of the
				Board.
(b) If any person is
				registered and is applying for re-registration, registration and renewal forms
				will be mailed approximately sixty (60) days before expiration date, or by May
				1st of each renewal year.
(c)
				Registration information may be obtained at any regional office of the Drug
				Enforcement Administration or by contacting the Wyoming State Board of
				Pharmacy.
(d) Each application for
				registration to handle any basic class of controlled substance listed in
				Schedule I (except to conduct chemical analysis with such classes), and each
				application for registration to manufacture a basic class of controlled
				substances listed in Schedule II, or to conduct research with any narcotic
				controlled substance listed in Schedule II, shall include the Controlled
				Substances Code Number for each basic class or substance to be covered by such
				registration.
(e) Each application
				shall include all information called for in the form, unless the item is not
				applicable, in which case this fact shall be indicated.
(f) Each application, attachment, or other
				document filed as part of an application, shall be signed by the applicant, if
				an individual; by a partner of the applicant, if a partnership; or by an
				officer of the applicant, if a corporation, corporate division association
				trust or other entity.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-13 - Filing of Application; Joint Filings

Current through July 13, 2024
(a) All
				applications for registration shall be submitted for filing to the Board. The
				appropriate registration fee and any required attachments must accompany the
				application.
(b) Any person
				required to obtain more than one registration may submit all applications in
				one package. Each application must be complete and should not refer to any
				accompanying application for required information.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-14 - Acceptance for Filing, Defective Applications

Current through July 13, 2024
(a) Applications
				submitted for filing are dated upon receipt. If found to be complete, the
				application will be accepted for filing. Applications failing to comply with
				the requirements of this part will not generally be accepted for filing. In the
				case of minor defects as to completeness, the Board may accept the application
				for filing with a request to the applicant for additional information. A
				defective application will be returned to the applicant with a statement of the
				reason for not accepting the application for filing. A defective application
				may be corrected and resubmitted for filing at any time prior to the expiration
				date.
(b) Accepting an application
				for filing does not preclude any subsequent request for additional information
				pursuant to this chapter and has no bearing on whether the application will be
				granted.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-15 - Additional Information

Current through July 13, 2024
(a) The Board may
				require an applicant to submit such documents or written statements of fact
				relevant to the application as it deems necessary to determine whether the
				application should be granted. The failure of the applicant to provide such
				documents or statements within a reasonable time after being requested to do so
				shall be deemed to be a waiver by the applicant of an opportunity to present
				such documents or facts for consideration by the Board in granting or denying
				the application.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-16 - Amendments to and Withdrawal of Applications

Current through July 13, 2024
(a) An application
				may be amended or withdrawn without permission of the Board at any time before
				the date on which the applicant receives an order to show cause pursuant to
				this chapter. An application may be amended or withdrawn with permission of the
				Board at any time where good cause is shown by the applicant or where the
				amendment or withdrawal is in the public interest.
(b) After an application has been accepted
				for filing, the request by the applicant that it be returned or the failure of
				the applicant to respond to official correspondence regarding the application
				within ten (10) days, when sent by registered or certified mail, shall be
				deemed to be a withdrawal of the application.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-17 - Administrative Review Generally

Current through July 13, 2024
The Board may inspect, or cause to be inspected, the
				  establishment of an applicant or registrant, pursuant to Section 46 of the Act.
				  The Board shall review the application for registration and other information
				  regarding an applicant in order to determine whether the applicable standards
				  of Sections 24 and 25 of the Act have been met by the
				  applicant.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-18 - Certificate of Registration; Denial of Registration

Current through July 13, 2024
(a) The
				Board shall issue a Certificate of Registration to an applicant if the issuance
				of registration or re-registration is required. In the event that the issuance
				of registration or re-registration is not in the public interest, the Board
				shall deny the application. Before denying any application, the Board shall
				issue an order to show cause and, if requested by the applicant, shall hold a
				hearing on the application.
(b) The
				Certificate of Registration shall contain the name, address, and the Drug
				Enforcement Administration registration number of the registrant, the activity
				authorized by the registration, the schedules and/or Controlled Substances Code
				Number of the controlled substances which the registrant is authorized to
				handle, the amount of fee paid (or exemption), and the expiration date of the
				registration. The registrant shall prominently display the Certificate of
				Registration at the registered location.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-19 - Suspension or Revocation of Registration

Current through July 13, 2024
(a) The Board may
				suspend any registration pursuant to Section 26(a) of the Act for any period of
				time it determines.
(b) The Board
				may revoke any registration pursuant to Section 26(a) of the Act.
(c) Before revoking or suspending any
				registration, the Board shall issue an order to show cause pursuant to this
				chapter and, if requested by the registrant, shall hold a hearing pursuant to
				this chapter. Notwithstanding the requirements of this section, however, the
				Board may suspend any registration pending a final order pursuant to this
				chapter.
(d) Upon service of the
				order of the Board suspending or revoking registration, the registrant shall
				immediately surrender his Certificate of Registration and shall:
(i) Deliver all controlled substances in his
				possession to the Board or its authorized agents; or
(ii) Place all controlled substances in his
				possession under seal.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-20 - Suspension of Registration Pending Final Order

Current through July 13, 2024
(a) The Board
				may suspend any registration simultaneously with or at any time subsequent to
				the service upon the registrant of an order to show cause why such registration
				should not be revoked or suspended, in any case where it finds that there is an
				imminent danger to the public health or safety. If the Board so suspends, it
				shall serve, together with the order to show cause pursuant to this chapter an
				order of immediate suspension which shall contain a statement of his findings
				regarding the danger to public health or safety.
(b) Upon service of the order of immediate
				suspension, the registrant shall promptly surrender his Certificate of
				Registration, and shall:
(i) Deliver all
				affected controlled substances in his possession to the Board or its authorized
				agents; or
(ii) Place all of such
				substances under seal.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-20 - Extension of Registration Pending Final Order

Current through July 13, 2024
In the event that an applicant for re-registration (who is
				  doing business under a registration previously granted and not revoked or
				  suspended) has applied for re-registration before the date on which the
				  existing registration is due to expire, and the Board has issued no order on
				  the application on the date on which the existing registration is due to
				  expire, the existing registration of the applicant shall automatically be
				  extended and continue in effect until the date on which the Board so issues its
				  order. The Board may extend any other existing registration under the
				  circumstances contemplated in this section even though the registrant failed to
				  apply for re-registration at least thirty (30) days before expiration of the
				  existing registration, with or without request by the registrant, if the Board
				  finds that such extension is not inconsistent with the public health and
				  safety.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-21 - Order to Show Cause

Current through July 13, 2024
(a) If, upon
				examination of the application for registration from any applicant and other
				information regarding the applicant, the Board is unable to make the
				determinations required by the applicable provisions to register the applicant,
				the Board shall serve upon the applicant an order to show cause why the
				registration should not be denied.
(b) If, upon information regarding any
				registrant, the Board determines that the registration of such registrant is
				subject to suspension or revocation, the Board shall serve upon the registrant
				an order to show cause why the registration should not be revoked or
				suspended.
(c) The order to show
				cause shall call upon the applicant or registrant to appear before the Board at
				a time and place stated in the order, which shall not be less than thirty (30)
				days after the date of receipt of the order. The order to show cause shall also
				contain a statement of the legal basis for such hearing and for the denial,
				revocation, or suspension of registration and a summary of the matters of fact
				and law asserted.
(d) Upon receipt
				of an order to show cause, the applicant or registrant must, if he desires a
				hearing, file a request for a hearing.. If a hearing is requested, the Board
				shall hold a hearing at the time and place stated in the order pursuant to this
				chapter.
(e) When authorized by the
				Board, any agent of the Board may serve the order to show cause, or the Board
				may serve such order by mailing the same by registered or certified mail to the
				last known address of the applicant or registrant.
MODIFICATION OR TERMINATION
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-22 - Modification of Registration

Current through July 13, 2024
Any registrant may apply to modify his registration to
				  authorize the handling of additional controlled substances by submitting a
				  letter of request to the Board. The letter shall contain the registrant's name,
				  address, registration number, and the substances and/or schedules to be added
				  to or deleted from his registration and shall be signed by the same person who
				  signed the most recent application for registration or re-registration. If the
				  registrant is seeking to handle additional controlled substances listed in
				  Schedule I for the purpose of research or instructional activities, he shall
				  attach one copy of a Federally approved research protocol describing each
				  research project involving the additional substances, or two copies of a
				  statement describing the nature, extent, and duration of such instructional
				  activities, as appropriate. No fee shall be required to be paid for the
				  modification. The request for modification shall be handled in the same manner
				  as an application for registration.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-23 - Termination of Registration

Current through July 13, 2024
The registration of any person shall terminate if and when
				  such person dies, ceases legal existence, discontinues business or professional
				  practice, or changes his name or address as shown on the Certificate of
				  Registration. Any registrant who ceases legal existence, discontinues business
				  or professional practice, or changes his name or address as shown on the
				  Certificate of Registration shall notify the Board promptly of such fact. In
				  the event of a change in name or address, the person may apply for a new
				  Certificate of Registration in advance of the effective date of such change by
				  filing an application and paying the appropriate fee in the same manner as an
				  application for new registration. The application shall be handled in the same
				  manner as an application for registration.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-24 - Security Requirements Generally

Current through July 13, 2024
(a) All applicants
				and registrants shall provide effective controls and procedures to guard
				against theft and diversion of controlled substances. In order to determine
				whether a registrant has provided effective controls against diversion, the
				Board shall use the security requirements set forth in standards for the
				physical security controls and operating procedures necessary to prevent
				diversion. Materials and construction which will provide a structural
				equivalent to the physical security controls set forth in this chapter may be
				used in lieu of the materials and construction described.
(b) Substantial compliance with the standards
				set forth in this chapter may be deemed sufficient by the Board after
				evaluation of the overall security system and needs of the applicant or
				registrant. In evaluating the overall security system of a registrant or
				applicant, the Board may consider any of the following factors as it may deem
				relevant to the need for strict compliance with security requirements:
(i) The type of activity conducted (e.g.,
				processing of bulk chemicals, preparing dosage forms, packaging, labeling,
				cooperative buying, etc.);
(ii) The
				type and form of controlled substances handled (e.g., bulk liquids or dosage
				units, usable powders or non-usable powders);
(iii) The quantity of controlled substances
				handled;
(iv) The location of the
				premises and the relationship such location bears on security needs;
(v) The type of building construction
				comprising the facility and the general characteristics of the building or
				buildings;
(vi) The type of vault,
				safe, and secure enclosures or other storage system (e.g., automatic storage
				and retrieval system) used;
(vii)
				The type of closures on vaults, safes, and secure enclosures;
(viii) The adequacy of electric detection and
				alarm systems, if any, including use of supervised transmittal lines and
				stand-by power sources;
(ix) The
				extent of unsupervised public access to the facility, including the presence
				and characteristics of perimeter fencing, if any;
(x) The adequacy of supervision over
				employees having access to manufacturing and storage areas;
(xi) The procedures for handling business
				guests, visitors, maintenance personnel, and non-employee service
				personnel;
(xii) The availability
				of local police protection or of the registrant's or applicant's security
				personnel, and;
(xiii) The adequacy
				of the registrant's or applicant's system for monitoring the receipt,
				manufacture, distribution, and disposition of controlled substances in its
				operations.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-25 - Physical Security Controls for Nonpractitioners; Storage Areas

Current through July 13, 2024
(a)
				Schedules I and II. Raw materials, bulk materials awaiting further processing,
				and finished products which are controlled substances listed in Schedule I or
				II shall be stored in one of the following secure storage areas:
(i) Where small quantities permit, a safe:
(A) When the safe has an Underwriters'
				Laboratories Burglary Rating of T-20, E or better, or the equivalent of such a
				safe;
(B) Which safe, if it weighs
				less than 750 pounds, is bolted, or cemented to the floor or wall in such a way
				that it cannot be readily removed; and
(C) Which safe, if necessary, depending upon
				the quantities and type of controlled substances stored, is equipped with an
				alarm system which, upon unauthorized entry, shall transmit a signal directly
				to a central protection company or a local or State police agency which has a
				legal duty to respond, or a 24-hour control station operated by the registrant,
				or such other protection as the Board may approve.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-26 - Physical Security Controls for Nonpractitioners; Manufacturing Areas

Current through July 13, 2024
All manufacturing activities (including processing,
				  packaging, and labeling) involving controlled substances listed in any schedule
				  shall be conducted in accordance with the following:
(a) All in-process substances shall be
				returned to the controlled substances storage area at the termination of the
				process. If the process is not terminated at the end of a workday (except where
				a continuous process or other normal manufacturing operation should not be
				interrupted), the processing area or tanks, vessels, bins, or bulk containers
				containing such substances shall be securely locked, with adequate security for
				the area or building. If such security requires an alarm, such alarm, upon
				unauthorized entry, shall transmit a signal directly to a central station
				protection company, or local or State police agency which has a legal duty to
				respond, or a 24-hour control station operated by the registrant.
(b) Manufacturing activities with controlled
				substances shall be conducted in an area or areas of clearly defined limited
				access which is under surveillance by an employee or employees designated in
				writing as responsible for the area. "Limited access" may be provided, in the
				absence of physical dividers such as walls or partitions, by traffic control
				lines or restricted space designation. The employee designated as responsible
				for the area may be engaged in the particular manufacturing operation being
				conducted: provided that he is able to provide continuous surveillance of the
				area in order that unauthorized persons may not enter or leave the area without
				his knowledge.
(c) During the
				production of controlled substances, the manufacturing areas shall be
				accessible to only those employees required for efficient operation. When it is
				necessary for employee maintenance personnel, non-employee maintenance
				personnel, business guests, or visitors to be present in or pass through
				manufacturing areas during production of controlled substances, the registrant
				shall provide for adequate observation of the area by an employee specifically
				authorized in writing.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-27 - Other Security Controls for Nonpractitioners

Current through July 13, 2024
(a) Before
				distributing a controlled substance to any person who the registrant does not
				know to be registered to possess the controlled substance, the registrant shall
				make a good faith inquiry either with the Drug Enforcement Administration or
				with the Wyoming State Board of Pharmacy, to determine that the person is
				registered to possess the controlled substance.
(b) The registrant shall design and operate a
				system to disclose to the registrant suspicious orders of controlled
				substances. The registrant shall inform the Board and the Drug Enforcement
				Administration of suspicious orders when discovered by the registrant.
				Suspicious orders include orders of unusual size, orders deviating
				substantially from a normal pattern, and orders of unusual frequency.
(c) The registrant shall notify the Drug
				Enforcement Administration and the Board of any theft or significant loss of
				any controlled substances upon discovery of such theft or loss. The registrant
				shall also complete an inventory regarding such theft or loss and submit a copy
				of such inventory to the Board. Thefts must be reported whether or not the
				controlled substances are subsequently recovered and/or the responsible parties
				are identified and action taken against them.
(d) Distribution of Controlled Substance
				Samples.
(i) The registrant shall not
				distribute any controlled substance listed in Schedule II or III as a
				complimentary sample to any potential or current customer or patient except in
				the following manner:
(A)
				Manufacturers/distributors of samples of controlled substance pharmaceutical
				products must be registered with the Board of Pharmacy and Drug Enforcement
				Administration before shipping controlled substances into the State of
				Wyoming.
(B)
				Manufacturers/distributors shall send to the Wyoming Board of Pharmacy a record
				of all such transactions involving the shipment of samples to a Wyoming
				registrant. The Board shall be notified of any unreasonable order requests or
				records shall be sent upon request. Records kept and provided by the
				manufacturer/distributor shall include:
(I)
				Manufacturer/Distributor name and DEA registration number.
(II) Address of
				Manufacturer/Distributor.
(III)
				Name, address and registration (DEA#) number of registrant receiving
				samples.
(IV) Drug name, strength,
				quantity/package, quantity/number of packages - total quantity sent to
				registrant.
(V) Date of shipment or
				delivery to the registrant.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-28 - Physical Security Controls for Practitioners

Current through July 13, 2024
(a) Controlled
				substances listed in Schedule I and II shall be stored in a securely locked,
				substantially constructed cabinet. However, pharmacies may disperse such
				substances throughout the stock of non-controlled substances in such a manner
				as to obstruct the theft or diversion of the controlled substances.
(b) Controlled substances listed in Schedules
				III, IV, and V shall be stored in a securely locked, substantially constructed
				cabinet. However, pharmacies may disperse such substances throughout the stock
				of non-controlled substances in such a manner as to obstruct the theft or
				diversion of the controlled substances.
(c) This section shall also apply to
				non-practitioners authorized to conduct research or chemical analysis under
				another registration.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 3 - FEES FOR REGISTRATION AND RE-REGISTRATION › Section 3-29 - Other Security Controls for Practitioners

Current through July 13, 2024
(a) The registrant
				shall not employ as an agent or employee any person, who has access to
				controlled substances, who has had an application for registration denied, or
				has had his registration revoked, suspended, or limited at any time.
(b) The registrant shall notify the Board and
				the Drug Enforcement Administration of the theft or significant loss of any
				controlled substances upon discovery of such loss or theft. The registrant
				shall also complete an inventory regarding such loss or theft and submit it in
				writing to the Board.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 4 - RECORDS AND INVENTORIES OF REGISTRANTS › Section 4-1 - Authority

Current through July 13, 2024
(a) These regulations are promulgated as
				authorized by the Wyoming Controlled Substances Act;
				W.S.
				35-7-1001 through -1101.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 4 - RECORDS AND INVENTORIES OF REGISTRANTS › Section 4-4 - Records and Inventory Requirements Generally

Current through July 13, 2024
(a) Each registered manufacturer,
				distributor, importer, and narcotic treatment program shall maintain
				inventories and records of controlled substances.
(b) Each registered individual practitioner
				shall keep records with respect to controlled substances which he prescribes or
				administers. Said practitioner shall keep additional records of such substances
				which he dispenses.
(c) Each
				registered pharmacy shall maintain records of controlled substances as follows:
(i) Schedules I and II shall be maintained
				separately from all other records of the pharmacy, and prescriptions for such
				substances shall be maintained in a separate written or electronic prescription
				file in consecutive numbers or by date.
(ii) Schedules III-V shall be maintained
				separately from all other records of the pharmacy and prescriptions for such
				substances shall be maintained in separate written or electronic prescription
				files for controlled substances in consecutive numbers or by date.
(iii) All written or electronic invoices for
				controlled substances shall be dated and signed when received by the pharmacist
				in charge or his/her designated agent. Invoices shall be maintained on file for
				two years and readily available for inspection by the Board.
(iv) All retail and institutional pharmacies
				shall maintain a perpetual inventory for all Schedule II controlled substances.
				This inventory shall be reconciled no less than once a quarter. Discrepancies
				discovered during reconciliation shall be reported to the Board within ten (10)
				calendar days of discovery. Only those discrepancies which are considered a
				significant loss or gain shall be reported. For the purpose of this section, a
				significant loss or gain shall exist whenever the actual inventory differs from
				the recorded inventory by more than five percent (5%) for any drug
				product.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 4 - RECORDS AND INVENTORIES OF REGISTRANTS › Section 4-5 - Inventory Requirements

Current through July 13, 2024
Every registrant required to keep records shall take a
				  physical inventory count of controlled substances during the first seven (7)
				  days of May of each year or other date approved by the Board.
(a) Each inventory shall contain a complete
				and accurate record of all controlled substances on hand on the date the
				inventory is taken.
(b) A separate
				inventory shall be made by a registrant for each registered address. Each
				inventory shall be kept at the registered location for which it is
				taken.
(c) A registrant may take an
				inventory either at the opening or close of business on the inventory date. The
				registrant shall indicate the time the inventory was taken on the inventory
				record.
(d) An inventory must be
				maintained in a legible written or printed form.
(e) Each registered pharmacy shall forward
				one (1) copy of the annual inventory to the office of the Board of Pharmacy,
				including the name of the pharmacy, date and time the inventory was taken, and
				the signature of the responsible person(s).
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 4 - RECORDS AND INVENTORIES OF REGISTRANTS › Section 4-6 - Drug Enforcement Administration (DEA) Order Form 222

Current through July 13, 2024
The order forms may be obtained only by those persons
				  registered to handle controlled substances in Schedules I and II.
(a) An order form may be executed only by or
				on behalf of the registrant named thereon and only if his registration is
				current.
(b) Order forms issued by
				the DEA will be serially numbered and issued with the name, address and
				registration number of the registrant, the authorized activity and the
				schedules of the registrant. This information cannot be altered or changed in
				any manner.
(c) Order forms shall
				be prepared using a typewriter, pen or the electronic equivalent.
(d) A registrant may authorize another
				individual to obtain and execute an order form on his behalf by executing a
				power of attorney. The power of attorney shall be filed with and retained for
				the same period as any order form bearing the signature of the grantor. The
				power of attorney shall be available for inspection.
(e) The purchaser registrant shall submit
				Copy 1 and Copy 2 of the order form to the supplier and retain Copy 3 with his
				own records. The supplier shall enter the suppliers DEA registration number,
				number of packages shipped, and the date shipped on Copies 1 and 2. If the
				supplier is another local registrant (not a registrant manufacturer or
				distributor), Copy 2 may be forwarded directly to the DEA Regional Office or
				the office of the Board of Pharmacy.
(f) The purchaser registrant shall record on
				Copy 3 of the order form the number of containers received on each item of the
				order form and the date received.
(g) Order forms and attached corresponding
				invoices shall be maintained separately from all other records of the
				registrant for a period of two years. Order forms shall be available for
				inspection during that time.
(h)
				The Controlled Substance Ordering System (CSOS) is authorized.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 4 - RECORDS AND INVENTORIES OF REGISTRANTS › Section 4-7 - Methamphetamine Precursor Records

Current through July 13, 2024
(a) The retail sale of non-liquid
				methamphetamine precursor drugs or liquid products with ephedrine or
				pseudoephedrine as the sole active ingredient shall be limited to amounts as
				specified in W.S. §
									
										35-7-1059.
(b) The seller shall maintain a written or
				electronic list of such sales (logbook) as described in W.S. §
									
										35-7-1059.
(c) The sale shall be documented as follows:
(i) The prospective purchaser shall present
				photo identification in accordance with W.S. §
										
											31-7-111 and W.S. §
										
											8-7-101.
(ii) The prospective purchaser shall sign the
				logbook and enter in the logbook his or her name, address and the date and time
				of the sale.
(iii) The seller shall
				determine that the name entered in the logbook corresponds to the name provided
				on such identification and that the date and time entered are
				correct.
(iv) The seller shall
				enter into the logbook the name of the product and the quantity sold.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-1 - Authority

Current through July 13, 2024
These rules are promulgated by the Wyoming Controlled
				  Substances Act; W.S. §
									
										35-7-1001
				  through
				  35-7-1060.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-4 - Definitions

Current through July 13, 2024
(a) "Audit Trail" means a record showing who
				has accessed an information technology application and what operations the user
				performed during a given period.
(b) "Authentication" means verifying the
				identity of the user as a prerequisite to allow access to the information
				application.
(c) "Digital
				signature" means an electronic identifier that:
(i) Is intended by the party using it to have
				the same force and effect as a manual signature;
(ii) Is unique to the authorized
				signer;
(iii) Is capable of
				verification;
(iv) Is under the
				sole control of the authorized signer; and
(v) Is linked to the prescription in such a
				manner that, if the prescription information is changed, the signature is
				invalidated.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-5 - Persons Entitled to Issue Prescriptions

Current through July 13, 2024
A prescription for a controlled substance shall be issued
				  only by a practitioner who is either registered or exempted from
				  registration.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-6 - Purpose of Issue of Prescription

Current through July 13, 2024
(a) A prescription for a controlled substance
				to be effective must be issued for a legitimate medical purpose by a
				practitioner acting in the usual course of his professional practice. The
				responsibility for the proper prescribing and dispensing of controlled
				substances is upon the prescribing practitioner, but a corresponding
				responsibility rests with the pharmacist who fills the prescription.
(b) A prescription may not be issued in order
				for an individual practitioner to obtain controlled substances for supplying
				the individual practitioner for the purpose of general dispensing to
				patients.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-7 - Manner of Issuance of Written, Typed or Computer Generated Prescriptions

Current through July 13, 2024
(a) All controlled substance prescriptions
				written by a Wyoming practitioner shall be issued on security paper, unless
				exempted under this Chapter for electronic transmission. Any controlled
				substance prescription written by a Wyoming practitioner issued on non-security
				paper may not be dispensed by a pharmacist.
(b) Any written, typed or computer generated
				prescription issued by a Wyoming practitioner for a Schedule II-V controlled
				substance except those issued as a medication order for administration in a
				long-term care facility or institutional facility shall meet the following
				requirements:
(i) Be printed on security
				paper, which includes the following features:
(A) If scanned or copied, "void" is displayed
				prominently throughout the front side of the document;
(B) Front side has erasure protection on
				green or blue background;
(C) Clear
				instructions printed on the paper indicating the front and back
				sides;
(D) Security warning list on
				the front or back;
(E) Quantity
				check-off boxes plus numeric forms of quantity values or alpha and numeric
				forms of quantity value (e.g. 20 and twenty); and
(F) Refill indicator (circle or check number
				of refills or "NR") plus numeric form of refill values or alpha and numeric
				form of refill values.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-8 - Persons Entitled to Fill Prescriptions

Current through July 13, 2024
A prescription for a controlled substance may only be filled
				  by a pharmacist or intern or pharmacy technician or technician-in-training
				  under direct supervision by a pharmacist, acting in the usual course of his/her
				  professional practice or by a registered practitioner.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-9 - Identification of a Patient

Current through July 13, 2024
(a) The pharmacist or employee under
				supervision must verify the identity of the person presenting a controlled
				substance prescription to the pharmacy for dispensing. This may be done by
				visual recognition. If identity is not established by visual recognition, a
				driver's license or similar photo identification form is acceptable
				documentation. The following information shall be recorded on the paper
				prescription, if identification is utilized: name, type of identification, and
				identification number.
(b) The name
				of the person receiving the dispensed drug is to be recorded on the
				prescription document, patient profile, or signature log, if an agent and not
				the patient receives the drug.
(c)
				This Section shall not apply to pharmacies that mail prescriptions to their
				patients. A note shall be entered on the prescription or patient's profile with
				the name and address of where the medication was mailed. Additionally, the date
				of such mailing shall be entered.
Wyoming Administrative Code › Agency 059 - Pharmacy, Board of › Sub-Agency 0002 - Commissioner of Drugs and Substances Control › Chapter 6 - ISSUING, FILING AND FILLING OF PRESCRIPTIONS › Section 6-10 - Dispensing of Narcotic Drugs for Maintenance Purposes

Current through July 13, 2024
The administering or dispensing directly (but not
				  prescribing) of narcotic drugs listed in any schedule to a narcotic drug
				  dependent person for the purpose of continuing his dependence upon such drugs
				  in the course of conducting a federally authorized clinical investigation in
				  the development of a narcotic addict rehabilitation program shall be deemed to
				  be within the meaning of the term "in the course of his professional practice
				  or research."